Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis Looks to Buy the Rest of Alcon
TheStreet.com
Monday, January 4, 2010 - 8:42am
tags:
Novartis, Alcon, M&A
Abbott's purchases bolster future
Chicago Tribune, IL
Sunday, January 3, 2010 - 11:46am
tags:
Abbott Laboratories, M&A, Solvay
Pfizer Must Face Menopause-Drug Award, Court Finds
Bloomberg
Sunday, January 3, 2010 - 11:44am
tags:
Pfizer, settlements, Provera
Facing Stunted Growth in ADHD Market, Shire Clicks on Twitter
BNET Pharma
Sunday, January 3, 2010 - 11:42am
tags:
Shire, ADHD, social media, twitter, Vyvanase
2010 FDA Decisions to Watch
Motley Fool
Sunday, January 3, 2010 - 11:39am
tags:
FDA, Pfizer, Nektar, MannKind, Afresa, Eli Lilly, Amylin, Dendreon, Vivus, Alkermes, Arena Pharmaceuticals, Orexigen
The FDA (Still) Hates Antibiotic Makers
Motley Fool
Sunday, January 3, 2010 - 11:37am
tags:
FDA, antibiotics, JNJ, ceftobiprole, Wyeth, Pfizer, Theravance
Will Biodel Be the Comeback Company of 2010?
Minyanville
Sunday, January 3, 2010 - 11:36am
tags:
Biodel, Viaject
AstraZeneca Strengthens Pipeline with Novexel, Forest Lab Deals
Seeking Alpha
Thursday, December 31, 2009 - 9:57am
tags:
Novexel, Forest Labs, AstraZeneca
Eli Lilly & Co. heiress Ruth Lilly dies at 94
Yahoo/AP
Thursday, December 31, 2009 - 9:32am
tags:
Eli Lilly
Is a Weak Dollar the Best Healthcare Bet?
TheStreet.com
Thursday, December 31, 2009 - 9:24am
tags:
Pfizer Pflubs -- You Expected Otherwise?
Motley Fool
Thursday, December 31, 2009 - 9:19am
tags:
Pfizer, figitumumab
King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results
Seeking Alpha
Thursday, December 31, 2009 - 9:18am
tags:
King, earnings
Pfizer Provides U.S. Regulatory Update On Prevnar 13 Vaccine
Yahoo
Wednesday, December 30, 2009 - 5:18pm
tags:
vaccines, Prevnar 13, Pfizer
Good News for Vical Candidate
Yahoo/Zacks.com
Wednesday, December 30, 2009 - 5:18pm
tags:
Vical, FDA, cancer, Allovectin-7
Myriad Genetics: Starting to Outperform
Seeking Alpha
Wednesday, December 30, 2009 - 1:39pm
tags:
Myriad Genetics
Drug stocks slip; Compugen rallies on stock sale
Marketwatch
Wednesday, December 30, 2009 - 1:38pm
tags:
drug stocks, CompuGen
It's Time for Adventrx to Follow Through on NDA
Seeking Alpha
Wednesday, December 30, 2009 - 9:50am
tags:
NDA, Adventrx
Valeant Pharmaceuticals' Retigabine Accepted For FDA Review
WSJ Online
Wednesday, December 30, 2009 - 9:35am
tags:
Valeant Pharmaceuticals, FDA, retigabine, epilepsy
Is the FDA Too Easy On Medical Devices?
WSJ Online
Wednesday, December 30, 2009 - 9:33am
tags:
FDA, medical devices
5-Star Stocks Poised to Pop: Repligen
Motley Fool
Wednesday, December 30, 2009 - 9:31am
tags:
Repligen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.